Exploring genetic differences to improve treatment for neurological diseases

Using Genetic Diversity to Manage Neurological Disease

NIH-funded research Scripps Research Institute, the · NIH-11002315

This study is looking at how our genes might play a role in neurological diseases like Alzheimer's, using smart computer techniques to see how genetic differences affect brain health, which could help create more personalized treatments for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11002315 on NIH RePORTER

What this research studies

This research investigates how genetic variations affect neurological diseases, particularly focusing on conditions like Alzheimer's disease. By utilizing advanced machine learning techniques, the study aims to understand how these genetic differences influence protein folding and stability, which are crucial for brain health. The approach involves analyzing genomic data to identify patterns that could lead to better management of diseases caused by protein misfolding. Patients may benefit from insights that could inform personalized treatment strategies based on their genetic profiles.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with genetic predispositions to neurodegenerative diseases, particularly those with known APOE alleles or other genetic markers associated with Alzheimer's disease.

Not a fit: Patients with neurological diseases not linked to genetic factors or those without identifiable genetic variations may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for neurological diseases by tailoring therapies to individual genetic profiles.

How similar studies have performed: Previous research has shown promise in using genetic insights to inform treatment strategies for neurodegenerative diseases, suggesting that this approach could yield valuable results.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.